Reduced serum paraoxonase 1 (PON1) activity in patients with schizophrenia treated with olanzapine but not quetiapine
Cüneyt Ünsal,1 Yakup Albayrak,1 Neslihan Albayrak,2 Murat Kuloğlu,3 Kenji Hashimoto41Department of Psychiatry, Namik Kemal University School of Medicine, Tekirdag, Turkey; 2Department of Cardiology, Kirklareli State Hospital, Kirklareli, Turkey; 3Department of Psychiatry, Akdeniz U...
Saved in:
Main Authors: | Ünsal C, Albayrak Y, Albayrak N, Kuloğlu M, Hashimoto K |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2013
|
Subjects: | |
Online Access: | https://doaj.org/article/9c6e136560ef477ca80f306468e212b0 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Increased serum levels of apoptosis in deficit syndrome schizophrenia patients: a preliminary study
by: Beyazyüz M, et al.
Published: (2016) -
Reduced serum brain-derived neurotrophic factor in patients with first onset vitiligo
by: Yanik ME, et al.
Published: (2014) -
Influence of olanzapine on serum prolactin levels and BMI in female patients with schizophrenia
by: Yang F, et al.
Published: (2018) -
Risperidone, quetiapine, and olanzapine adjunctive treatments in major depression with psychotic features: a comparative study
by: Gabriel A
Published: (2013) -
Decreased serum levels of brain-derived neurotrophic factor in schizophrenic patients with deficit syndrome
by: Akyol ES, et al.
Published: (2015)